Preventing Mother-to-Child Transmission of HIV and HBV

To help CDC increase understanding of the effectiveness of using maternal tenofovir containing combination drug during the second and third trimesters of pregnancy for the prevention of mother-to-child transmission of HIV and HBV in co-infected mothers.
Funding Partners:
  • Gilead Sciences, Inc.
Program Partners:
  • CDC's National Center for Chronic Disease Prevention and Health Promotion
Program Location:
  • China